ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small ... MarketWatch (press release) Rituximab, azathioprine, methotrexate, or mycophenolate mofetil therapy are also used, but these drugs are associated with an increased risk of infection, bone marrow suppression, certain types of cancer, serious and sometimes fatal infusion reactions ... |
